Preventice Solutions
Preventice Solutions (now Boston Scientific Cardiac Diagnostics) provides FDA-cleared BodyGuardian wearable ECG monitors and AI-driven arrhythmia analysis (BeatLogic, ECG Insight) to physicians, clinics, and hospitals for continuous remote cardiac monitoring, operating as a wholly owned subsidiary of Boston Scientific Corporation.
- Company typePrivate
- Founded2007
- HeadquartersHouston, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Preventice Solutions does
Preventice Solutions, founded in 2007 and headquartered in Houston, Texas, developed a portfolio of mobile cardiac health solutions built around the BodyGuardian family of FDA-cleared, wearable ECG monitors designed for continuous 24/7 use. The BodyGuardian MINI and BodyGuardian MINI PLUS collect cardiac rhythm data from patients and transmit it to healthcare providers for arrhythmia diagnosis, with proprietary AI algorithms BeatLogic and ECG Insight performing automated rhythm analysis and clinical interpretation to reduce physician review burden. BodyGuardian 360 powered by Prevounce extends the platform with EMR integration and workflow tools for practice management connectivity.
The company operated a B2B2C model selling devices and subscription monitoring services to physicians, clinics, and hospitals, who then prescribed monitors to patients. Revenue derived from three streams: hardware sales of the BodyGuardian devices, recurring subscription-based remote monitoring services, and reimbursement and billing support (including Personapay patient billing integration and Medicare-certified diagnostic facilities obtained through the acquisition of AMI Cardiac Monitoring). Pricing was quote-based through healthcare provider ordering systems with multi-year contracts and Medicare/insurance reimbursement pathways.
In 2021, Boston Scientific Corporation acquired Preventice Solutions for $925 million, integrating it as Boston Scientific Cardiac Diagnostics Inc., a wholly owned subsidiary. The acquisition embedded Preventice's BodyGuardian technology and AI tools within Boston Scientific's broader cardiac diagnostics portfolio (HeartLogic, AVVIGO+, LUX-Dx II+) and gave it access to Boston Scientific's global distribution network ($16.7B in 2024 net sales, up 17.6% YoY). The company now serves healthcare providers across North America and Europe.
Preventice Solutions firmographics
Firmographics- Name
- Preventice Solutions
- Legal name
- Boston Scientific Cardiac Diagnostics Inc.
- Website
- https://preventicesolutions.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Acquired
- Headcount range
- 501–1,000 employees
- Short description
- Preventice Solutions (now Boston Scientific Cardiac Diagnostics) provides FDA-cleared BodyGuardian wearable ECG monitors and AI-driven arrhythmia analysis (BeatLogic, ECG Insight) to physicians, clinics, and hospitals for continuous remote cardiac monitoring, operating as a wholly owned subsidiary of Boston Scientific Corporation.
- Ownership category
- akta.pro rank
Preventice Solutions industry classification
Industry- Product category
- Remote Cardiac Monitoring Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where Preventice Solutions is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Markets served
Preventice Solutions business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- Wearable Cardiac Monitoring Devices: Sale of BodyGuardian remote cardiac monitors (BodyGuardian MINI, BodyGuardian MINI PLUS) to healthcare providers and patients. Devices are FDA-cleared and designed for extended wear (24/7 usage, waterproof).
- Remote Patient Monitoring Services: Subscription-based monitoring services where healthcare professionals receive continuous ECG data transmission and AI-powered analysis to support cardiac arrhythmia diagnosis.
- Reimbursement and Billing Services: Patient billing and reimbursement support services including Personapay integration for patient payments, Medicare-certified diagnostic facilities through acquired AMI Cardiac Monitoring.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | BodyGuardian monitoring services for healthcare providers |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Preventice Solutions product offering
Product offeringCore offering
Preventice Solutions develops and sells the BodyGuardian portfolio of FDA-cleared wearable cardiac monitors (BodyGuardian MINI and MINI PLUS) that patients wear 24/7 to collect continuous ECG data. The devices are paired with AI-powered diagnostic software (BeatLogic and ECG Insight) for arrhythmia detection and clinical interpretation, along with BodyGuardian 360 powered by Prevounce for EMR integration and clinical workflow management. The company operates a B2B2C model, selling primarily to healthcare providers who prescribe the monitors to their patients.
Product overview
Preventice Solutions, acquired by Boston Scientific in 2021 for $925 million, operates as Boston Scientific Cardiac Diagnostics and offers the BodyGuardian™ remote cardiac monitoring portfolio. The portfolio centers on wearable ECG devices (BodyGuardian MINI and MINI PLUS) that collect continuous cardiac data from patients wearing the monitors 24/7. These devices integrate with AI-powered diagnostic software including BeatLogic™ for automated arrhythmia detection and ECG Insight™ for clinical interpretation support. The offering also includes workflow integration solutions such as BodyGuardian 360 powered by Prevounce, enabling electronic medical record (EMR) connectivity and streamlined clinical workflows for healthcare providers. The product ecosystem combines comfortable, waterproof patient-worn hardware with cloud-based data analytics platforms to deliver actionable cardiac diagnostics.
Differentiator
Problem solved
Functional benefit
Brands
- BodyGuardian: Remote cardiac monitoring system - a comfortable, waterproof heart monitor that patients can wear 24/7, delivering ECG data to physicians for diagnosis.
- BodyGuardian MINI
- BodyGuardian MINI PLUS
- BeatLogic
- ECG Insight
- BodyGuardian 360 powered by Prevounce
Products and services
- BodyGuardian MINI A compact, wearable cardiac monitor designed for patients that provides continuous ECG monitoring in a small, unobtrusive, waterproof form factor suitable for 24/7 wear during normal daily activities. Prescribed by physicians for arrhythmia detection and cardiac diagnosis.
- BodyGuardian MINI PLUS An enhanced version of the BodyGuardian MINI with expanded monitoring capabilities for longer-term cardiac surveillance. A wearable, waterproof cardiac monitor providing continuous ECG data collection for physician diagnosis.
- BeatLogic An AI-powered cardiac rhythm analysis platform that identifies arrhythmias and delivers actionable accuracy in ECG interpretation for healthcare professionals. Part of Boston Scientific's BeatLogic suite for automated ECG analysis.
- ECG Insight An AI-driven ECG analysis tool that provides clinical insights and interpretation support for healthcare professionals reviewing cardiac monitoring data, synthesizing and retrieving clinical information to support physician decision-making.
- BodyGuardian 360 powered by Prevounce A comprehensive cardiac monitoring platform combining BodyGuardian hardware with Prevounce software for integrated patient management, workflow optimization, and EMR connectivity for healthcare providers.
Quantifiable outcome
- Wearable ECG monitors market projected to grow at 23.4% CAGR from $4.78B (2025) to $13.67B (2030)
Companies that use Preventice Solutions
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Preventice Solutions technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Preventice Solutions partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Preventice Solutions competitors and assessment
Company assessmentDirect peers
- InfoBionic: InfoBionic offers MoMe Kardia, a remote cardiac monitoring platform with AI arrhythmia detection; competes directly with BodyGuardian in the ambulatory ECG/MCT segment targeting cardiology practices.
- iRhythm Technologies: iRhythm is a direct competitor in ambulatory cardiac monitoring, offering the Zio patch-based ECG monitor with AI-assisted arrhythmia detection. Both companies compete for the same cardiologist/electrophysiologist customers and rely on CPT-code-based reimbursement.
- AliveCor: AliveCor makes KardiaMobile, a consumer/clinical ECG device with AI-driven arrhythmia detection, competing with BodyGuardian MINI in the short-duration, single-lead ECG category and increasingly in clinical remote monitoring.
Broad incumbents
- GE HealthCare: GE HealthCare offers MUSE cardiology information systems and broader cardiac diagnostics infrastructure; competes at the workflow and EMR-integration layer where BodyGuardian 360 also plays.
- Boston Scientific (parent): Boston Scientific is Preventice's parent company and a broader incumbent in cardiac care, offering insertable cardiac monitors (LUX-Dx), CRM devices, and HeartLogic heart failure diagnostics. Overlapping but larger portfolio that distributes BodyGuardian.
- Medtronic: Medtronic offers the LINQ insertable cardiac monitor and broader cardiac diagnostics portfolio, competing for the same cardiology customers with both implantable and external monitoring solutions.
- Philips (BioTel): Philips acquired BioTel (formerly LifeWatch) and provides remote cardiac monitoring services and MCT/event monitors, making it a broad incumbent competitor in the ambulatory cardiac monitoring services market.
Emerging players
- Apple (Apple Watch ECG): Apple Watch includes FDA-cleared ECG and atrial fibrillation detection features; while consumer-grade, it increasingly encroaches on the low-acuity end of the ambulatory cardiac monitoring market where BodyGuardian MINI operates.
- Biotricity: Biotricity offers Bioflux, a remote cardiac monitoring device with cloud platform; an emerging player competing in mobile cardiac telemetry with a comparable B2B2C physician-prescribed model.
- Qardio: Qardio offers remote cardiac monitoring devices and connected health platforms; smaller-scale competitor in the RPM space with overlap in cardiology practice adoption models.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Preventice Solutions social profiles
Digital presencePreventice Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Preventice Solutions leadership team
Management profileNumber of profiles
Preventice Solutions funding detail
Funding detailFunding overview
Funding rounds2 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Preventice Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Preventice Solutions
What does Preventice Solutions do?
Preventice Solutions develops and sells the BodyGuardian portfolio of FDA-cleared wearable cardiac monitors (BodyGuardian MINI and MINI PLUS) that patients wear 24/7 to collect continuous ECG data. The devices are paired with AI-powered diagnostic software (BeatLogic and ECG Insight) for arrhythmia detection and clinical interpretation, along with BodyGuardian 360 powered by Prevounce for EMR integration and clinical workflow management. The company operates a B2B2C model, selling primarily to healthcare providers who prescribe the monitors to their patients.
Is Preventice Solutions a public or private company?
Preventice Solutions is a private company. It is classified as corporate owned and is currently acquired.
When was Preventice Solutions founded?
Preventice Solutions was founded in 2007. It employs 501 to 1,000 people.
Where is Preventice Solutions based?
Preventice Solutions is headquartered in Houston, United States, in the North America region.
How does Preventice Solutions make money?
Three revenue lines are on record. Wearable Cardiac Monitoring Devices are the primary driver. The others are remote Patient Monitoring Services and reimbursement and Billing Services.
Who are Preventice Solutions's main competitors?
Direct peers on record are InfoBionic, iRhythm Technologies and AliveCor. Broad incumbents are GE HealthCare, Boston Scientific (parent), Medtronic and Philips (BioTel). Emerging players are Apple (Apple Watch ECG), Biotricity and Qardio.
Does Preventice Solutions have an API?
No public API is recorded for Preventice Solutions.
What industry is Preventice Solutions in?
Preventice Solutions's product category is Remote Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.